Locations:
SearchDr. Steven Nissen shares why these studies matter
The recent European Society of Cardiology (ESC) 2016 Congress may have been short on headline-grabbing trials, but that doesn’t mean there weren’t study presentations with very important implications for many, many patients.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Two such studies — the NORSTENT comparison of drug-eluting and bare-metal coronary stents, and a fascinating analysis out of Wayne State University evaluating long-term exposure to low levels of both LDL cholesterol and blood pressure — stood out for Cleveland Clinic Cardiovascular Medicine Chairman Steven Nissen, MD.
In this short video, Dr. Nissen explains how and why each study matters to cardiovascular practice.
Advertisement
Advertisement
How our first century has impacted cardiovascular practice
Review offers comprehensive assessment of the landscape for wearables and more
Preserving trust in research requires vigilance and consensus around statistical nuances
Cardiac surgeon Patrick Vargo, MD, reflects on his first year as Cleveland Clinic staff
Improved risk prediction for patients is at the heart of Dr. Aaron Weiss’ research interests
Centralization would likely bring better outcomes, experts say, but may not be feasible
Dr. Daniel Burns on mentorship, robotic valve surgery, statistics and more
JACC review makes the case and outlines how to ensure oversight